National Alliance Launches Laundry List Of Biosimilar Uptake Strategies
Lack Of Transparency And Misaligned Incentives Have Hindered US Biosimilar Adoption
The National Alliance of Healthcare Purchaser Coalitions has worked with seven regional organizations and over 60 employers to identify five areas where US employers can take specific actions to expand access to biosimilars.
You may also be interested in...
Savings achieved in the US through the use of generics and biosimilars hit a new high in 2020, reaching $338bn, according to new figures released by the AAM.
While it currently sits in fourth place, Amneal’s co-CEO Chirag Patel has laid out ambitions for the firm to become the number one supplier of affordable medicines in the US.
Industry veteran and serial entrepreneur Daphne Koller tells In Vivo about how her company, Insitro, is unleashing the potential of computational biology and machine learning to discover new drug compounds.